News Details

( 19 May 2022)
AstraZeneca Pharma I - Board to consider FY22 results & Final Dividend on May 26, 2022

AstraZeneca Pharma India Ltd has informed BSE that a meeting of the Board of Directors of the Company will be held on May 26, 2022, inter alia:

1. To consider and approve the Audited Financial Results of the Company for the quarter and year ended March 31, 2022.

2. To recommend final dividend, if any, on the equity shares of the Company for the financial year ended March 31, 2022.

Further, the 'Trading Window' remains closed for all Designated Persons, from March 16, 2022 to May 28, 2022 (both days inclusive) in terms of AstraZeneca Pharma India Limited - Code of Conduct for Prevention of Insider Trading framed under Securities and Exchange Board of India (Prohibition of Insider Trading) Regulations 2015.